Prostate cancer castration. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Prostate Cell Line, Tumor Seminal Vesicles Tumor Cells, Cultured Epithelial Cells Testis Neoplastic Stem Cells Chromosomes, Human, Pair 8 Epididymis Stromal Cells Cell Nucleus Rectum Neoplastic Cells, Circulating Urogenital System

Organisms5

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C Mice, Inbred C57BL

Diseases31

Prostatic Neoplasms Neoplasms, Hormone-Dependent Prostatic Hyperplasia Adenocarcinoma Neoplasm Metastasis Disease Progression Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Prostatic Neoplasms, Castration-Resistant Breast Neoplasms Carcinoma Neoplasms Lung Neoplasms Neoplasm Recurrence, Local Ovarian Neoplasms Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Prostatitis Pancreatic Neoplasms Disease Models, Animal Neovascularization, Pathologic Urinary Bladder Neoplasms Colorectal Neoplasms Uterine Cervical Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating

Chemicals and Drugs80

Prostate-Specific Antigen Androgens Receptors, Androgen Androgen Antagonists Testosterone Dihydrotestosterone Tosyl Compounds Flutamide Tumor Markers, Biological Androgen Receptor Antagonists Anilides Antineoplastic Agents, Hormonal Finasteride Antineoplastic Agents RNA, Messenger Neoplasm Proteins 5-alpha Reductase Inhibitors Azasteroids Metribolone Gonadotropin-Releasing Hormone Leuprolide Taxoids Androstenols RNA, Small Interfering Anticarcinogenic Agents Nitriles Phenylthiohydantoin Cancer Vaccines 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Glutamate Carboxypeptidase II Cyproterone Estradiol PTEN Phosphohydrolase DNA, Neoplasm Goserelin Antineoplastic Agents, Phytogenic Androgen-Binding Protein Testosterone Congeners Gonadal Steroid Hormones Antigens, Neoplasm Clonixin Prostatic Secretory Proteins Proto-Oncogene Proteins c-akt Estrogens Racemases and Epimerases RNA, Neoplasm Tumor Suppressor Protein p53 Receptors, Estrogen Transcription Factors Androstane-3,17-diol Cholestenone 5 alpha-Reductase MicroRNAs Proto-Oncogene Proteins c-bcl-2 Estramustine Tumor Suppressor Proteins Clusterin Receptor, erbB-2 DNA-Binding Proteins Cyproterone Acetate Glutathione S-Transferase pi Proto-Oncogene Proteins Ki-67 Antigen Drug Implants Butorphanol Testosterone Propionate Enzyme Inhibitors Antibodies, Monoclonal Luteinizing Hormone Kallikreins Haptoglobins Steroid 17-alpha-Hydroxylase Diethylstilbestrol Paclitaxel Hormones DNA Primers Oncogene Proteins, Fusion Insulin-Like Growth Factor Binding Protein 3 Ketoprofen Zeranol Carotenoids

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Castration Orchiectomy Prostatectomy Early Detection of Cancer Neoplasm Grading Xenograft Model Antitumor Assays Neoplasm Staging Reverse Transcriptase Polymerase Chain Reaction Neoplasm Transplantation Prognosis Transplantation, Heterologous Immunohistochemistry Digital Rectal Examination Risk Factors Blotting, Western Gene Expression Profiling Case-Control Studies Transurethral Resection of Prostate Follow-Up Studies Risk Survival Analysis Prospective Studies Retrospective Studies Biopsy Survival Rate Risk Assessment Combined Modality Therapy Sensitivity and Specificity Treatment Outcome Biopsy, Needle Odds Ratio Brachytherapy Incidence Disease-Free Survival Cohort Studies Transfection Tumor Burden Oligonucleotide Array Sequence Analysis Organ Size Tissue Array Analysis Kaplan-Meier Estimate SEER Program Antineoplastic Combined Chemotherapy Protocols Polymerase Chain Reaction Multivariate Analysis Registries Predictive Value of Tests Radiotherapy Nomograms Disease Models, Animal Drug Screening Assays, Antitumor Logistic Models Molecular Targeted Therapy Radiotherapy Dosage Radiotherapy, Conformal Models, Biological Reproducibility of Results Questionnaires Immunoenzyme Techniques Flow Cytometry Mass Screening Gene Knockdown Techniques Confidence Intervals Clinical Trials as Topic Radiotherapy, Intensity-Modulated In Situ Hybridization, Fluorescence Random Allocation Ovariectomy Radiotherapy Planning, Computer-Assisted Anesthesia, Local Drug Administration Schedule ROC Curve Chemotherapy, Adjuvant

Psychiatry and Psychology2

Anxiety, Castration Smoking

Phenomena and Processes42

Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Genetic Predisposition to Disease Signal Transduction Cell Division Drug Resistance, Neoplasm Risk Time Factors Down-Regulation Cell Growth Processes Cell Survival Sensitivity and Specificity Genotype Odds Ratio Up-Regulation Cell Movement Dose-Response Relationship, Drug Transfection Promoter Regions, Genetic DNA Methylation Organ Size Cell Cycle Polymorphism, Genetic Mutation Gene Expression Nomograms Gene Silencing Gene Fusion Base Sequence Genes, Tumor Suppressor RNA Interference Chromosomes, Human, Pair 8 Diet Phosphorylation Transcription, Genetic Polymorphism, Single Nucleotide Alleles Genes, Neoplasm Germ-Line Mutation Drug Synergism Phenotype

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Animal Welfare Quality of Life

Humanities1

Quality of Life

Information Science10

Survival Rate Incidence SEER Program Registries Base Sequence Radiotherapy, Conformal Questionnaires Molecular Sequence Data Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups3

European Continental Ancestry Group African Americans Survivors

Health Care32

Risk Factors Watchful Waiting Case-Control Studies Follow-Up Studies Risk Survival Analysis Prospective Studies Retrospective Studies Survival Rate Risk Assessment Sensitivity and Specificity Treatment Outcome Odds Ratio Incidence Disease-Free Survival Age Factors Cohort Studies Kaplan-Meier Estimate National Cancer Institute (U.S.)SEER Program Multivariate Analysis Registries Predictive Value of Tests Nomograms Logistic Models Reproducibility of Results Questionnaires Mass Screening Confidence Intervals Clinical Trials as Topic Random Allocation ROC Curve

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostate Castration Orchiectomy Prostatic Neoplasms Prostate-Specific Antigen Androgens Receptors, Androgen Androgen Antagonists Cell Line, Tumor Testosterone Prostatectomy Neoplasms, Hormone-Dependent Prostatic Hyperplasia Dihydrotestosterone Gene Expression Regulation, Neoplastic Tosyl Compounds Mice, Nude Adenocarcinoma Early Detection of Cancer Neoplasm Metastasis Disease Progression Flutamide Tumor Markers, Biological Androgen Receptor Antagonists Prostatic Intraepithelial Neoplasia Anilides Antineoplastic Agents, Hormonal Bone Neoplasms Seminal Vesicles Apoptosis Cell Proliferation Neoplasm Invasiveness Finasteride Neoplasm Grading Antineoplastic Agents Xenograft Model Antitumor Assays RNA, Messenger Neoplasm Staging Tumor Cells, Cultured Reverse Transcriptase Polymerase Chain Reaction Neoplasm Proteins Neoplasm Transplantation Genetic Predisposition to Disease Prognosis 5-alpha Reductase Inhibitors Transplantation, Heterologous Immunohistochemistry Digital Rectal Examination Risk Factors Blotting, Western Prostatic Neoplasms, Castration-Resistant Watchful Waiting Breast Neoplasms Carcinoma Gene Expression Profiling Azasteroids Neoplasms Signal Transduction Case-Control Studies Cell Division Metribolone Transurethral Resection of Prostate Drug Resistance, Neoplasm Follow-Up Studies Risk Mice, SCID Time Factors Gonadotropin-Releasing Hormone Lung Neoplasms Leuprolide Taxoids Down-Regulation Survival Analysis Cell Growth Processes Neoplasm Recurrence, Local Prospective Studies Androstenols Retrospective Studies RNA, Small Interfering Ovarian Neoplasms Biopsy Cell Survival Survival Rate Risk Assessment Anticarcinogenic Agents Nitriles Phenylthiohydantoin Combined Modality Therapy Sensitivity and Specificity Cancer Vaccines 3-Oxo-5-alpha-Steroid 4-Dehydrogenase United States Treatment Outcome Genotype Glutamate Carboxypeptidase II Cyproterone Colonic Neoplasms Estradiol Biopsy, Needle Odds Ratio

No FAQ available that match "prostate cancer castration"